The Economics of Cell and Gene Therapy with Oscar Bronsther & Carolina Escobar
??Spencer Smith, CSFS?
?? SVP - ParetoHealth || ??? Host - Self-Funded w/ Spencer || ?? “Self-Fund or Die”
Dr. Oscar Bronsther and Dr. Carolina Escobar from Interlink joined me this week to discuss the exciting and scary world of cell and gene therapy, CRISPR, and how we fund these amazing medical advances.?
Tune in through the links below:
LISTEN/WATCH NOW
"It's progress we couldn't have envisioned decades ago." - Oscar
“I felt interested in being part of something bigger than my practice and something that will impact even more people that I was able to in the hospital.” - Carolina
In addition to me attempting to act smart enough to be in the same room as these two, we covered their wholistic approach to this emerging scientific field, which promises potential cures for rare and debilitating diseases, but often comes with 7-figure price tags. The rare genetic diseases are known as “orphan diseases”, and there have been some recent incredible advances in detecting them early on in life.
We talked about what this all means for individuals as well as the insurance space as a whole, and how it has the potential to increase medical costs in this country even further.?
Chapters:
00:00:00 Meet Oscar and Carolina
00:09:16 Genetic Therapy Solutions for Orphan Diseases
00:14:39 Detecting and Targeting Single Gene Mutations
00:26:52 CRISPR Technology
00:30:08 Equitable Access To Gene/Cell Therapy
00:37:21 How Do We Finance This?
00:46:13 The Ethical Concerns Of Cell/Gene Therapy
00:59:45 Economic Implications of This Technology
?? SVP - ParetoHealth || ??? Host - Self-Funded w/ Spencer || ?? “Self-Fund or Die”
2 周Make sure to vote today, not just with your hands for the next President, but also with your ears on this amazing podcast episode!